Pipeline Medical sells to licensed practices only. Product information on this page is intended for qualified practitioners.
Rx Only
Buy Evolus® with confidence.
JEUVEAU® and Evolysse™, shipped direct from Evolus. Ordered through Pipeline, with expert support at every step.
1 Planning estimate only. This is not a quote, an offer, a guarantee of savings, account approval, product availability or program eligibility.
Built for aesthetic practices
A clearer path from product interest to practice support.
Start with the products and economics that matter to your practice. Pipeline can then review account fit, purchasing options, and the operational needs your team manages every day.
01
One account across more of your practice
Review eligible aesthetic products alongside medical, surgical and pharmaceutical purchasing.
02
See the economics before you request access
Compare the costs you enter today with the Pipeline pricing model used at review.
03
Support beyond product ordering
Share product interest, buying volume and timing so the account conversation starts informed.
04
Connect to Evolus practice resources
Official Evolux®, Evolus Rewards™, education and Medical Affairs resources in one place.
Loyalty, education and clinical support
Official Evolus programs and resources.
Product access is one part of the relationship. Eligible practices can review official Evolus loyalty, education, account and clinical-support resources, plus the events and resources Pipeline runs for its own accounts.
Evolux®
Practice loyalty
Loyalty benefits, Signature Subscription information and pricing structures, as published by Evolus.
Evolus Rewards™
Patient loyalty
Provider-side participation, patient enrollment, reward mechanics and current program terms.
Academy
Evolus Academy
Official Evolus education for healthcare professionals, including clinical learning for injectors.
MyEvolus
Practice account access
Create or reach an official Evolus account for the provider resources Evolus makes available.
Club Evolus™
Patient membership
A consumer membership covering 20 units of JEUVEAU® per treatment, with a minimum of 90 days between treatments.
Clinical studies
The published record
Five JEUVEAU® trials in more than 2,100 patients, and the Evolysse™ CLIN 2101 study, as published by Evolus.
Medical Affairs
A direct line to Evolus Medical Affairs
When a clinical or scientific question belongs with the manufacturer, your Pipeline rep routes it to Evolus Medical Affairs and follows it to an answer.
Pipeline exclusive
Events and resources only Pipeline accounts get
Pipeline-only injector events, training sessions and purchasing resources built for our accounts — not available through the manufacturer directly.
Next step
Tell us which programs matter
Pipeline walks you through what applies to your account — no hunting through manufacturer sites.
4-quarter estimate
What could your Evolus purchasing look like through Pipeline?
Enter expected quarterly volume and the average acquisition cost your practice pays today. You see the headline number before we ask for your contact information.
Estimate your 4-quarter purchasing difference
Step 1 · CalculateEvolus portfolio
Review the products relevant to your practice.
Use official manufacturer information for indications, prescribing, safety, clinical and directions-for-use decisions.
JEUVEAU®
prabotulinumtoxinA-xvfs · prescription neuromodulator
Review the current official Evolus healthcare-provider information and Full Prescribing Information before use.
EVOLYSSE™ FORM & SMOOTH
injectable hyaluronic acid · dermal filler
Review official Evolus healthcare-provider information, indications, Important Safety Information and the applicable Directions for Use.
How to order
A simpler path from estimate to account review.
Establish relevance with the estimator, then move into the account and purchasing process.
1
Estimate the difference
Quarterly volume and current cost
2
Get the detailed report
Practice details, 4-quarter summary
3
Account review
Credentials, product interest, volume
4
Order
Current pricing and availability
Manufacturer-reported clinical data
What the trials showed.
Figures below are reported by Evolus in its published clinical materials. They are provided for provider review and are not a claim of outcome for any patient.
JEUVEAU®
Head-to-head phase III, 540 adults
A non-inferiority study compared prabotulinumtoxinA with onabotulinumtoxinA in moderate to severe glabellar lines. JEUVEAU® was shown to be not inferior.
87.2%
of JEUVEAU® patients studied saw improvement at Day 30 (n=235)
82.8%
of BOTOX® Cosmetic patients studied saw improvement at Day 30 (n=244)
68% & 70%
of patients had a 2-grade or better physician- and patient-rated improvement at Day 30 in two US studies, compared with 1% for placebo
5 trials
more than 2,100 patients studied; effects can last up to 4 months as muscle activity gradually returns
Rzany B. Aesthet Surg J. 2020;40(4):413-429. Beer K. Dermatol Surg. 2019;45(11):1381-1393. A non-inferiority study is conducted to show that the effect of a treatment is not worse than the original treatment. Results based on a 1-grade improvement may not be clinically meaningful. BOTOX® Cosmetic is a registered trademark of Allergan, Inc.
EVOLYSSE™ FORM & SMOOTH
CLIN 2101, 140 patients at six months
Patients evaluated their own nasolabial folds at set time points. Reported results are immediate and last up to one year in most patients, with optimal treatment.
64%
were less bothered by how their nasolabial folds look when smiling
65%
were less bothered by how they look when relaxed
65%
were less bothered by how deep their nasolabial folds were
Shape
named Evolysse™ “Best Dermal Filler” at the Shape Skin Awards
Data on File. CLIN 2101 Clinical Study Report. Chaponost, France: Symatese SAS, 2024. In the clinical study, patients (N=140) were asked to evaluate their results at specific time points. Evolysse™ Form and Evolysse™ Smooth Patient Labeling. Approved for wrinkles in dynamic areas of the face, especially nasolabial folds, in adults 22 and older.
Product information and safety
Prescription products carry prescription obligations.
Injectable and prescription products require appropriate licensure, clinical judgment, training, and review of the applicable manufacturer labeling, Full Prescribing Information, Important Safety Information and Directions for Use. This page supports practice purchasing and account navigation. It does not provide patient-specific medical advice.
JEUVEAU®
EVOLYSSE™ FORM & SMOOTH
FAQ
Questions practices ask first.
Licensed healthcare providers and aesthetic practices reviewing Evolus purchasing options through Pipeline Medical.
No. It is a planning estimate based on the volume and costs you enter and the applicable Pipeline pricing assumptions. It is not a quote, an offer, a guarantee of savings, account approval or a guarantee of availability.
The estimate needs a comparison point. Your entered cost prepares the estimate and gives Pipeline context for follow-up. Do not enter patient information.
Pipeline sends the calculation summary and reviews the practice information you provide. Access, pricing, availability and program terms remain subject to review.
Pipeline can point eligible practices to the official Evolus resources and support the Pipeline account process. Eligibility, terms, points, rebates and benefits are determined by Evolus.
Yes. Pipeline supports medical, surgical, pharmaceutical and aesthetic purchasing. Available categories depend on the practice and account.
Request account support
Ready to review your Evolus purchasing options?
Start with the estimate, or ask Pipeline to review the account path, available resources and next steps for your practice.